Literature DB >> 17898587

Dihydrotestosterone stimulates proliferation and differentiation of fetal calvarial osteoblasts and dural cells and induces cranial suture fusion.

Ines C Lin1, Alison E Slemp, Catherine Hwang, Miguel Sena-Esteves, Hyun-Duck Nah, Richard E Kirschner.   

Abstract

BACKGROUND: The higher prevalence of metopic and sagittal suture synostosis in male infants suggests a role for androgens in early craniofacial development. These experiments characterize the influence of androgen stimulation on growth and differentiation of fetal dural and calvarial bone cells and on cranial suture fusion.
METHODS: Primary murine fetal (E18) dural cells and calvarial osteoblasts were isolated and cultured. Cells were treated for 48 hours with 5alpha-dihydrotestosterone (0 to 1000 nM). Cell proliferation was examined by nonradioactive proliferation assay; mRNA expression of alkaline phosphatase, transforming growth factor (TGF)-beta1, and the bone matrix proteins osteopontin, osteocalcin, and type 1 collagen was determined by reverse-transcriptase polymerase chain reaction. In separate experiments, intact fetal calvariae were grown in tissue culture with 10 nM 5alpha-dihydrotestosterone for 7 and 14 days and then examined histologically.
RESULTS: Androgen stimulation at 5 nM increased proliferation of fetal dural cells by 46.0 percent and of fetal calvarial osteoblasts by 20.5 percent. Dural expression of osteopontin, osteocalcin, and type 1 collagen was enhanced by 5alpha-dihydrotestosterone, as was that of TGF-beta1 and alkaline phosphatase. Androgen stimulation increased calvarial osteoblast expression of alkaline phosphatase and TGF-beta1 but induced little change in expression of osteocalcin, osteopontin, and type 1 collagen. In tissue culture, 5alpha-dihydrotestosterone stimulated osteoid formation and fusion of sagittal sutures.
CONCLUSIONS: Androgen stimulation of dural cells and osteoblasts isolated from fetal calvaria promotes cell proliferation and osteoblastic differentiation and can induce cranial suture fusion. These results suggest that sex steroid hormone signaling may stimulate sutural osteogenesis by means of osteodifferentiation of dural cells, thus explaining the male prevalence of nonsyndromic craniosynostosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17898587     DOI: 10.1097/01.prs.0000279527.99734.bf

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  10 in total

Review 1.  Skull base development and craniosynostosis.

Authors:  Susan I Blaser; Nancy Padfield; David Chitayat; Christopher R Forrest
Journal:  Pediatr Radiol       Date:  2015-09-07

Review 2.  Abnormal skull shape.

Authors:  Susan I Blaser
Journal:  Pediatr Radiol       Date:  2008-06

3.  Effect of a single injection of testosterone enanthate on 17β estradiol and bone turnover markers in hypogonadal male patients.

Authors:  V Camozzi; G Bonanni; A Frigo; M Piccolo; S Ferasin; M Zaninotto; M Boscaro; G Luisetto
Journal:  J Endocrinol Invest       Date:  2014-10-16       Impact factor: 4.256

4.  Osteoblast differentiation profiles define sex specific gene expression patterns in craniosynostosis.

Authors:  Sarah S Park; Richard P Beyer; Matthew D Smyth; Christine M Clarke; Andrew E Timms; Theo K Bammler; Brendan D Stamper; Brigham H Mecham; Jennifer A Gustafson; Michael L Cunningham
Journal:  Bone       Date:  2015-03-07       Impact factor: 4.398

5.  Molecular analysis of coronal perisutural tissues in a craniosynostotic rabbit model using polymerase chain reaction suppression subtractive hybridization.

Authors:  James J Cray; Phillip H Gallo; Emily L Durham; Joseph E Losee; Mark P Mooney; Sandeep Kathju; Gregory M Cooper
Journal:  Plast Reconstr Surg       Date:  2011-07       Impact factor: 4.730

6.  Activation of the IGF1 pathway mediates changes in cellular contractility and motility in single-suture craniosynostosis.

Authors:  Zeinab Al-Rekabi; Marsha M Wheeler; Andrea Leonard; Adriane M Fura; Ilsa Juhlin; Christopher Frazar; Joshua D Smith; Sarah S Park; Jennifer A Gustafson; Christine M Clarke; Michael L Cunningham; Nathan J Sniadecki
Journal:  J Cell Sci       Date:  2015-12-11       Impact factor: 5.285

7.  Signaling pathways implicated in androgen regulation of endocortical bone.

Authors:  Kristine M Wiren; Anthony A Semirale; Joel G Hashimoto; Xiao-Wei Zhang
Journal:  Bone       Date:  2009-11-04       Impact factor: 4.398

8.  Dihydrotestosterone, a robust promoter of osteoblastic proliferation and differentiation: understanding of time-mannered and dose-dependent control of bone forming cells.

Authors:  Hnin Ei Thu; Isa Naina Mohamed; Zahid Hussain; Ahmad Nazrun Shuid
Journal:  Iran J Basic Med Sci       Date:  2017-08       Impact factor: 2.699

9.  Stanozolol promotes osteogenic gene expression and apposition of bone mineral in vitro.

Authors:  Giulia Ghiacci; Simone Lumetti; Edoardo Manfredi; Daniele Mori; Guido Maria Macaluso; Roberto Sala
Journal:  J Appl Oral Sci       Date:  2018-11-08       Impact factor: 2.698

10.  Estrogen/estrogen receptor alpha signaling in mouse posterofrontal cranial suture fusion.

Authors:  Aaron W James; Alexander A Theologis; Samantha A Brugmann; Yue Xu; Antoine L Carre; Philipp Leucht; Katherine Hamilton; Kenneth S Korach; Michael T Longaker
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.